Skip to main content
. Author manuscript; available in PMC: 2021 Nov 2.
Published in final edited form as: J Cardiovasc Electrophysiol. 2020 Jul 16;31(9):2275–2283. doi: 10.1111/jce.14632

Figure 1. Flow Chart of Patient Selection.

Figure 1.

There was no significant difference in all-cause mortality,cardiovascular death, cardiovascular hospitalization and stroke or transient ischemic attack between the HFpEF-AF and HFrEF-AF. Compared with the rate control strategy, rhythm control in HFpEF-AF patients offered no survival benefits,whereas rhythm control decrease cardiovascular mortality in HFrEF-AF patients.

AAD=antiarrhythmic drug;AF=atrial fibrillation;AVN= atrioventricular node;HF=heart failure;

HFpEF-AF= atrial fibrillation and heart failure with preserved left ventricular ejection fraction;

HFrEF-AF= atrial fibrillation and heart failure with reduced left ventricular ejection fraction.